Abstract

Synthesis and biomedical research of bimetallic gold-silver nanoparticles (Au–Ag NPs) have gained much attention due to their unique properties. Antibacterial mechanism of gold-silver nanoparticles is a current topic of interest in nanomedicine engineering. We used three routes in the synthesis of Au–Ag NPs alloy: i) Co-reduction of [HOOC-4-C6H4NN]AuCl4/AgNO3, ii) Seeding of AuNPs-COOH/AgNO3 and iii) immobilization of AgNPs over the parent AuNPs-COOH. Two mild reducing agents, NaBH4 and 9-BBN (9-borabicyclo(3.3.1)nonane), were used. Colloidal alloy nanoparticles structure was confirmed using transmission electron microscopy (TEM) and X-ray photoelectron spectroscopy (XPS). The particles reduced using NaBH4 were larger (~20 nm) than those synthesized using 9-BBN (<10 nm). The synthesized nanoparticles showed high stability under notoriously leaching conditions of chloride-containing electrolytes. Moreover, we studied the Au–Ag NPs antibacterial activity against the growth of Gram-negative Escherichia coli ATCC strain 25922 and Gram-positive Staphylococcus aureus ATCC strain 29213. The antibacterial mechanisms were evaluated by studying the time-dependent generation of reactive oxygen species (ROS). A major destruction of the bacterial cell wall and leakage of cell components were observed by scanning electron microscopy (SEM), which is clearly visible towards E. coli more than S. aureus bacterial strain. The destruction of the bacterial cell wall was further confirmed by detecting the DNA leakage using gel electrophoresis. The synergistic effect of gold enhanced the antibacterial properties, however, with low cytotoxicity to human dermal fibroblast cells. This study deals with the important aspects of time-dependent mechanisms of the antibacterial action of Au–Ag NPs since the leaching out of Ag ion is slow compared to AgNPs. The Au–Ag NPs alloy efficiently tackles microbial activity that can be controlled to minimize cytotoxicity and thus opens their future applications as antibacterial agents.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.